Barinthus Biotherapeutics plc - American Depositary Shares BRNS 深 沪
等待开盘 08-06 09:30:00 美东时间
1.38
+0.090
+6.98%
华盛通- 最 高1.4681
- 今 开1.32
- 成交量 8.56万股
- 最 低 1.2888
- 昨 收 1.29
- 总市值 5566.84万
- 52周最高 2.92
- 市盈率 静 --
- 换手率 0.21%
- 52周最低 0.64
- 委 比 69.01%
- 总股本 4033.94万
- 历史最高 17.99
- 量 比 0.94
- 振 幅 13.90%
- 历史最低 0.64
- 每 手 1
- 风险率 0.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Barinthus Biotherapeutics Q1 EPS $(0.49) Misses $(0.36) Estimate
Barinthus Biotherapeutics (NASDAQ:BRNS) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.36) by 36.11 percent. This is a 22.5 percent decrease over losses of $(0.40) per
05-07 21:20
Barinthus Biotherapeutics Restructures Leadership with New CFO
Barinthus Biotherapeutics ( ($BRNS) ) has issued an update. Barinthus Biotherap...
05-07 20:28
美股大行评级 | 高盛：上调Adaptive Biotechnologies评级至"买入"，目标价从8美元升至9美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1110125309827231744.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer：维持Amprius Technologies(AMPX)"跑赢大市"评级，目标价从14美元升至15美元</p> <p>• 韦德布什：维持Monte Rosa Therapeutics(GLUE)"跑
03-24 07:31
H.C. Wainwright Sticks to Its Buy Rating for Barinthus Biotherapeutics (BRNS)
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Barinthus Biotherape...
03-21 18:46
美股大行评级 | 潜在涨幅224%！Ultragenyx制药获Piper Sandler上调目标价至140美元，维持“超配”评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1085846677098434561.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler：维持Ultragenyx制药(RARE)"超配"评级，目标价从135美元升至140美元</p> <p>• Leerink Partners：维持ARS Pharmaceuticals(SPRY)
01-14 09:51
Barinthus Biotherapeutics Appoints New Chief Scientific Officer
An announcement from Barinthus Biotherapeutics ( ($BRNS) ) is now available. Ba...
2024-11-26 05:35
Barinthus Biotherapeutics Reports Promising IM-PROVE II Trial Results
The latest update is out from Barinthus Biotherapeutics ( ($BRNS) ). Barinthus ...
2024-11-16 00:30
Barinthus Biotherapeutics Elevates Griffiths to COO
Barinthus Biotherapeutics ( ($BRNS) ) has issued an announcement. Barinthus Bio...
2024-09-06 04:29
Analysts’ Top Healthcare Picks: Avid Bioservices (CDMO), Barinthus Biotherapeutics (BRNS)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
2024-06-07 21:10
Barinthus Biotherapeutics Breakthrough in Hepatitis B Treatment
Barinthus Biotherapeutics (BRNS) just unveiled an announcement. Barinthus Bioth...
2024-06-07 05:12
